What is the ticker symbol for Outlook Therapeutics?

Outlook Therapeutics trades under the ticker OTLK on NASDAQ.

What sector does Outlook Therapeutics operate in?

Outlook Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze OTLK in a portfolio?

PortView shows OTLK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Outlook Therapeutics (OTLK) Stock Analysis

NASDAQHealthcareBiotechnology

$0.62-0.90%

1-year price historyRange $0.20 – $2.47

52-week range$0.62

$0.16$2.54

What Outlook Therapeutics does

Outlook Therapeutics, Inc. is a biopharmaceutical company in the advanced stages of clinical development, focused on inventing and bringing to market monoclonal antibody treatments for various eye conditions. Its flagship drug candidate, ONS-5010, is an ophthalmic formulation of bevacizumab currently undergoing crucial Phase III clinical trials. This investigational product is being evaluated for its potential to treat wet age-related macular degeneration and other serious retinal diseases. The company has forged strategic collaboration and licensing agreements with several partners, including IPCA Laboratories Limited, Laboratorios Liomont, S.A. de C.V., BioLexis Pte. Ltd., and Zhejiang Huahai Pharmaceutical Co., Ltd. Incorporated in 2010, the firm was formerly known as Oncobiologics, Inc., changing its name to Outlook Therapeutics, Inc. in November 2018. Its corporate base is located in Iselin, New Jersey.

Key metrics

Market cap

$115.47M

P/E (TTM)

-0.59

EPS (TTM)

$-1.04

Beta

0.80

Dividend yield

0.00%

Revenue / share

$-0.05

50-day avg

$1.16

200-day avg

$0.88

52-week high

$2.54

52-week low

$0.16

CEO

Robert Charles Jahr

ETFs linked to OTLK

Broad-market and Healthcare sector ETFs an investor holding Outlook Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how OTLK fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze OTLK in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Outlook Therapeutics?: Outlook Therapeutics trades under the ticker OTLK on NASDAQ.
Which exchange is OTLK listed on?: OTLK is listed on NASDAQ.
What sector does Outlook Therapeutics operate in?: Outlook Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze OTLK in a portfolio?: PortView shows OTLK's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.